five things you should know about invokana
The Food and Drug Administration’s recent safety review of Invokana resulted in new warnings for diabetics taking the medication. Meyers & Flowers wants you to know what the new warnings mean if you or a loved one have taken Invokana?
What is Invokana
Each year, millions of Americans work tirelessly with their doctors to find the right combination of medications to help treat their diabetes as pharmaceutical companies seem to continually churn out new classes of diabetes drugs that promise to control blood glucose levels in new and better ways. Invokana is one such medication. Invokana (canagliflozin) is part of a new class of diabetes drugs known as a sodium-glucose cotransporter-2 (SGLT2) inhibitor. It works by blocking the reabsorption of glucose by the kidneys. As the excess sugar is excreted in the urine, patients are able to keep their blood sugar or glucose levels lower.
Ketoacidosis linked to Invokana
The FDA approved Invokana in 2013. It was immediately hailed as a breakthrough in diabetes management. However, within two years, the FDA began issuing warnings about the drug. The Agency was investigating if the type 2 diabetes medications, canagliflozin, dapagliflozin and empagliflozin potentially caused ketoacidosis, a serious, at times deadly, condition where the body produces high levels of ketones or blood acids which could lead to hospitalization, diabetic coma, kidney damage and even death.
The FDA’s Warning for Invokana Patients
On December 4, 2015, after an in-depth study, the FDA determined that official warnings needed to be added to the labels of Invokana and other sodium-glucose cotransporter-2 (SGLT2) drugs to address the risk of patients developing ketoacidosis and serious urinary tract infections caused by these medications.
Symptoms of Ketoacidosis and Urinary Tract Infections
According to the FDA, patients taking Invokana and other SGLT2 medications are encouraged to see immediate medical attention if they have any of the following symptoms of ketoacidosis or urinary tract infections:
- Abdominal Pain
- Difficulty breathing
- Burning when urinating
- Blood in the urine
- Needing to urinate often or urgently
- Pain in the lower part of the stomach or pelvic area
What are my rights if I have been injured by Invokana?
Numerous Invokana patients have reported developing ketoacidosis when they were simply looking for an effective and safe way to control their diabetes. If you or a loved one have taken Invokana and have been diagnosed with this serious, life -threatening condition, you have rights.
“When it was introduced to the public, Invokana seemed like a potentially promising treatment for millions of diabetics in the U.S.,” said Peter Flowers, Partner at Meyers & Flowers, a top law firm in Chicago. “However, as we quickly learned, instead of being a safe option for diabetes management, patients began reporting instances of ketoacidosis and serious urinary tract infections. We are ready to protect these injured patients as they explore litigation against Mitsubishi Tanabe Pharma and Janssen Pharmaceuticals.”
Contact Meyers & Flowers to learn more about your litigation options. We have a long history of pursuing litigation against major pharmaceutical and have won settlements and awards for millions, and in some cases billions, of dollars for our clients.